Ezra launches direct-to-consumer full-body MR scanning program
advertisement
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

MRI Homepage

New study calls for pre-biopsy MR scans in prostate cancer assessment Better able to detect cancers that likely require treatment

NIH researchers uncover potential new indication of severe MS Based on dark-rimmed marks on patient brains

Bayer sells MR endorectal coil product line to DxTx Medical Helps image prostate, colorectal, cervix and surrounding pelvic anatomy

Trendy magnetic eyelashes are the latest potential hazard in the MR suite Can cause artifacts, detach during procedures

MR brain scans reveal differences in US personnel formerly stationed in Cuba Incurred from intensely loud noises in homes and hotel rooms

Study advises personalized breast cancer screenings for cancer survivors May benefit from MR alone, rather than MR and mammography

Knitting raises thousands for Scottish MR scanner fundraising campaign Improving access to care in remote Shetland Islands

CT and MR waiting times costing Canadians over $3 billion Need $4.4 billion to update imaging stock, says report

MR and ultrasound biopsies combined can detect prostate cancers, says study Detect up to 33 percent more tumors together

Demand on the rise for MR-guided radiotherapy, says new report Compound annual growth rate of 20 percent through 2028

Ezra launches full-body MR
scanning program

Ezra launches direct-to-consumer full-body MR scanning program

por John R. Fischer , Staff Reporter
Ezra, a manufacturer of cancer detection technology, launched a direct-to-consumer full-body MR scanning program this past month in the New York area.

The service provides patients with MR scans that can detect up to 11 forms of cancer in men and 13 in women.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“Patients that will benefit the most from our service are those who are coming in for screening — to check their organs, as part of their annual health regimen,” Justin Melia, head of marketing at Ezra, told HCB News. “Previous cancer patients will also benefit from active screening because they are at higher risk of developing additional cancers.”

The program is divided into multiple plans to make scans more affordable and to bring in as many people as possible. The Ezra full-body scan costs $1,950, while single-region scans are available for as little as $675. In addition, members can pay in 12 monthly installments through a no-interest payment plan.

Scans are performed using 3T MR systems with curated protocols for high quality imaging. Ezra is currently seeking approval for use of its proprietary AI technology in prostate detection and segmentation, and expects it to help radiologists in lesion detection. It plans to expand its use to cancer detection in other organs following approval.

The opening of the program follows that of Ezra’s MR-based prostate cancer screening program back in January, which leverages new technologies to detect prostate cancer as early as possible so that patients can avoid unnecessary prostate biopsies. It has since attracted almost 1,000 members and scanned hundreds of men.

“Right now we cover the top cancers by incidence and ones that are very amenable to detection by MR,” said Melia. “As MR technology improves, there is certainly room to add additional cancers.”

In addition to accumulating a board of medical advisers in the last four months, Ezra has expanded to eight new imaging facilities across the five boroughs of New York and New Jersey.

It plans to expand its presence to other cities by the end of the 2019.

MRI Homepage


You Must Be Logged In To Post A Comment